Use of Multivariate Data Analysis in Bioprocessing
08 April 2015
The ever increasing demand of biotherapeutics, together with the pressure to contain healthcare costs have motivated biotech manufacturers to focus on process optimization. Of a variety of approaches, use of advanced sampling techniques, new sensor technologies, and analyzers has emerged as a topic of interest to the scientific community at large. Implementation of these tools, however, inadvertently results in large complex datasets with underlying multivariate interactions.
Japanese researchers study carbon nanotubes with drug delivery applications
07 April 2015
Researchers across the world are scrambling to invent new technologies made out of graphene, perfectly flat sheets of carbon atoms that are only one atom thick. For instance, South Korea's Samsung is developing foldable screens made out of graphene, while the European Union is devoting €1 billion ($1.1 billion) to study the potential material of the future, which is a truly 2-D material, with no dangling bonds to bind with surfaces above or below it.
The top companies in med tech: 2014 revenue results
07 April 2015
Big med tech companies come in three types: med tech pure-plays; major conglomerates that include non-healthcare businesses; and mixed drug/device players. All three of these groups have been making big moves to transform themselves this year.
NIH Makes Initial Revisions to Guidelines for Genomic Data Analysis in the Cloud
06 April 2015
The National Institutes of Health issued a position statement this week revising its existing polices on use of cloud computing services for storing and analyzing controlled access data stored in the Database of Genotypes and Phenotypes (dbGAP).
06 April 2015
The Office of the National Coordinator for Health Information Technology (ONC) announced today the availability of online tools and resources designed to help states participating in the State Innovation Models initiative improve health care quality and lower costs.
Index Ventures banks €650M for its new tech fund
06 April 2015
Index Ventures now has 650 million more euros to invest. The venture group, which has two big teams active on both sides of the Atlantic in life sciences as well as tech, filed documents with the SEC noting that its new Index Ventures Growth III--domiciled in Jersey--is fully sold.
Malaysia at unexpected center of vaccine meetings that highlight regional focus
06 April 2015
Two gatherings in Kuala Lumpur, Malaysia this week, although held separately, came close, but not quite, to bringing together the twin issues of vaccines and the practice of halal by Muslims who comprise a third of Asia's population. Apparently, neither of the two primary gatherings had the concerns of the other on its agenda.
India likely to extend price caps to more HIV, TB meds: Reuters
03 April 2015
After stirring up protest by expanding its list of drugs subject to price caps late last year, India is considering adding more to the list. This time, health officials are likely to add more drugs that treat HIV and tuberculosis, Reuters reports.
Watch out, pharma. Fitch says the M&A party could come with a hangover
03 April 2015
Biopharma has been on a bona fide dealmaking binge. Trouble is, that binge is starting to get too expensive--and too risky. That's what Fitch Ratings says in a new report that cautions against fast-and-loose dealmaking.
VC heavyweights back a $150M NYC biotech fund with Lilly and Celgene in tow
03 April 2015
New York City's nascent biotech investment fund is ready to get rolling, recruiting some venture capital partners to join Eli Lilly ($LLY), Celgene ($CELG) and GE Ventures ($GE) with hopes of pouring $150 million into the local life sciences startup scene.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024